dsip-safety-data DSIP DSIP (Delta Sleep-Inducing Peptide): Benefits,

About the Author Maryke Louw is a chartered physiotherapist with more than 20 years' experience and a Masters Degree in Sports Injury Management

Watermann I, Schmitt B, Stellmacher F, Mller J, Gaber R, Kugler C, et al

This particular arrangement was first isolated and characterized in 1993 by researchers at the University of Zagreb, Croatia, led by Dr

Key gaps include: No large-scale randomised controlled trials in humans the evidence basis for clinical use is extrapolated from animal data and small pilot studies No long-term safety data effects beyond 1216 weeks are not well characterised Variable results in human sleep trials some early human studies showed modest or inconsistent effects on sleep architecture compared to animal data, suggesting the translation may not be linear No FDA approval DSIP is not approved for any therapeutic use in the United States Stability concerns DSIP degrades relatively quickly in circulation

Updated July 24, 2026 at 8:55 AM PDT For the latest stories on the science of healthy living, subscribe to NPR's Health newsletter

It does not, and the FDA's reasoning here is worth taking seriously